A novel vitronectin receptor integrin (alpha v beta x) is responsible for distinct adhesive properties of carcinoma cells. Cheresh DA, Smith JW, Cooper HM, Quaranta V (1989) Cell 57: 59-69 Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice. Zhang W, Yancey PG, Su YR, Babaev VR, Zhang Y, Fazio S, Linton MF (2003) Circulation 108: 2258-63 Lysophosphatidic acid targets vascular and oncogenic pathways via RAGE signaling. Rai V, Touré F, Chitayat S, Pei R, Song F, Li Q, Zhang J, Rosario R, Ramasamy R, Chazin WJ, Schmidt AM (2012) J Exp Med 209: 2339-50 Hepatic apo E expression is required for remnant lipoprotein clearance in the absence of the low density lipoprotein receptor. Linton MF, Hasty AH, Babaev VR, Fazio S (1998) J Clin Invest 101: 1726-36 The major laminin receptor of mouse embryonic stem cells is a novel isoform of the alpha 6 beta 1 integrin. Cooper HM, Tamura RN, Quaranta V (1991) J Cell Biol 115: 843-50 Laminin receptors in the retina: sequence analysis of the chick integrin alpha 6 subunit. Evidence for transcriptional and posttranslational regulation. de Curtis I, Quaranta V, Tamura RN, Reichardt LF (1991) J Cell Biol 113: 405-16 TLR sorting by Rab11 endosomes maintains intestinal epithelial-microbial homeostasis. Yu S, Nie Y, Knowles B, Sakamori R, Stypulkowski E, Patel C, Das S, Douard V, Ferraris RP, Bonder EM, Goldenring JR, Ip YT, Gao N (2014) EMBO J 33: 1882-95 Pertussis toxin inhibits chemotactic peptide-stimulated generation of inositol phosphates and lysosomal enzyme secretion in human leukemic (HL-60) cells. Brandt SJ, Dougherty RW, Lapetina EG, Niedel JE (1985) Proc Natl Acad Sci U S A 82: 3277-80 Enhancement of chemotactic factor-stimulated neutrophil oxidative metabolism by leukotriene B4. Gay JC, Beckman JK, Brash AR, Oates JA, Lukens JN (1984) Blood 64: 780-5 Lymphokine-activated killer activity induced by in vivo interleukin 2 therapy: predominant role for lymphocytes with increased expression of CD2 and leu19 antigens but negative expression of CD16 antigens. Weil-Hillman G, Fisch P, Prieve AF, Sosman JA, Hank JA, Sondel PM (1989) Cancer Res 49: 3680-8 Virus glycosylation: role in virulence and immune interactions. Vigerust DJ, Shepherd VL (2007) Trends Microbiol 15: 211-8 Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation. Hata AN, Breyer RM (2004) Pharmacol Ther 103: 147-66 Reduced atherosclerotic lesions in mice deficient for total or macrophage-specific expression of scavenger receptor-A. Babaev VR, Gleaves LA, Carter KJ, Suzuki H, Kodama T, Fazio S, Linton MF (2000) Arterioscler Thromb Vasc Biol 20: 2593-9 Unique pathway for cholesterol uptake in fat cells. Fazio S, Linton MF (2004) Arterioscler Thromb Vasc Biol 24: 1538-9 Establishment of an EBV-positive lymphoblastoid cell line that grows as a lymphoma in nude mice and expresses membrane CD2 molecules. Roncella S, Ramarli D, Cooper MK, Forni M, Caretto P, Rowe M, Francia di Celle P, Sessarego M, Foà R, Forni G (1990) Int J Cancer 45: 299-307 Structural basis for ligand recognition and activation of RAGE. Koch M, Chitayat S, Dattilo BM, Schiefner A, Diez J, Chazin WJ, Fritz G (2010) Structure 18: 1342-52 Class A scavenger receptors, macrophages, and atherosclerosis. Linton MF, Fazio S (2001) Curr Opin Lipidol 12: 489-95 Altered expression of Ly49 inhibitory receptors on natural killer cells from MHC class I-deficient mice. Salcedo M, Diehl AD, Olsson-Alheim MY, Sundbäck J, Van Kaer L, Kärre K, Ljunggren HG (1997) J Immunol 158: 3174-80 The class A scavenger receptor, macrophage receptor with collagenous structure, is the major phagocytic receptor for Clostridium sordellii expressed by human decidual macrophages. Thelen T, Hao Y, Medeiros AI, Curtis JL, Serezani CH, Kobzik L, Harris LH, Aronoff DM (2010) J Immunol 185: 4328-35 Prostaglandin E2-induced changes in alveolar macrophage scavenger receptor profiles differentially alter phagocytosis of Pseudomonas aeruginosa and Staphylococcus aureus post-bone marrow transplant. Domingo-Gonzalez R, Katz S, Serezani CH, Moore TA, Levine AM, Moore BB (2013) J Immunol 190: 5809-17 The melanoma growth stimulatory activity receptor consists of two proteins. Ligand binding results in enhanced tyrosine phosphorylation. Cheng QC, Han JH, Thomas HG, Balentien E, Richmond A (1992) J Immunol 148: 451-6 Plasmodium berghei infection in mice induces liver injury by an IL-12- and toll-like receptor/myeloid differentiation factor 88-dependent mechanism. Adachi K, Tsutsui H, Kashiwamura S, Seki E, Nakano H, Takeuchi O, Takeda K, Okumura K, Van Kaer L, Okamura H, Akira S, Nakanishi K (2001) J Immunol 167: 5928-34 Direct effects of T-bet and MHC class I expression, but not STAT1, on peripheral NK cell maturation. Robbins SH, Tessmer MS, Van Kaer L, Brossay L (2005) Eur J Immunol 35: 757-65 Ontogeny and differentiation of murine natural killer cells and their receptors. Sivakumar PV, Puzanov I, Williams NS, Bennett M, Kumar V (1998) Curr Top Microbiol Immunol 230: 161-90 Different preparations of zymosan induce glycogenolysis independently in the perfused rat liver. Involvement of mannose receptors, peptide-leukotrienes and prostaglandins. Kimura K, Shiota M, Mochizuki K, Ohta M, Sugano T (1992) Biochem J 283 ( Pt 3): 773-9 N-formyl peptide receptor phosphorylation domains differentially regulate arrestin and agonist affinity. Key TA, Foutz TD, Gurevich VV, Sklar LA, Prossnitz ER (2003) J Biol Chem 278: 4041-7 Regulation of formyl peptide receptor agonist affinity by reconstitution with arrestins and heterotrimeric G proteins. Key TA, Bennett TA, Foutz TD, Gurevich VV, Sklar LA, Prossnitz ER (2001) J Biol Chem 276: 49204-12 Partial phosphorylation of the N-formyl peptide receptor inhibits G protein association independent of arrestin binding. Bennett TA, Foutz TD, Gurevich VV, Sklar LA, Prossnitz ER (2001) J Biol Chem 276: 49195-203 Identification of determinants of ligand binding affinity and selectivity in the prostaglandin D2 receptor CRTH2. Hata AN, Lybrand TP, Breyer RM (2005) J Biol Chem 280: 32442-51 Arrestin variants display differential binding characteristics for the phosphorylated N-formyl peptide receptor carboxyl terminus. Potter RM, Key TA, Gurevich VV, Sklar LA, Prossnitz ER (2002) J Biol Chem 277: 8970-8 Embryonic fibroblasts that are genetically deficient in low density lipoprotein receptor-related protein demonstrate increased activity of the urokinase receptor system and accelerated migration on vitronectin. Weaver AM, Hussaini IM, Mazar A, Henkin J, Gonias SL (1997) J Biol Chem 272: 14372-9 Epidermal growth factor and platelet-derived growth factor-BB induce a stable increase in the activity of low density lipoprotein receptor-related protein in vascular smooth muscle cells by altering receptor distribution and recycling. Weaver AM, McCabe M, Kim I, Allietta MM, Gonias SL (1996) J Biol Chem 271: 24894-900 A lymphocyte-specific Ltk tyrosine kinase isoform is retained in the endoplasmic reticulum in association with calnexin. Snijders AJ, Ho SC, Haase VH, Pillai S, Bernards A (1997) J Biol Chem 272: 1297-301 Interactive sites in the MyD88 Toll/interleukin (IL) 1 receptor domain responsible for coupling to the IL1beta signaling pathway. Li C, Zienkiewicz J, Hawiger J (2005) J Biol Chem 280: 26152-9 S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway. Ghavami S, Rashedi I, Dattilo BM, Eshraghi M, Chazin WJ, Hashemi M, Wesselborg S, Kerkhoff C, Los M (2008) J Leukoc Biol 83: 1484-92 Structural determinants of arylacetic acid nonsteroidal anti-inflammatory drugs necessary for binding and activation of the prostaglandin D2 receptor CRTH2. Hata AN, Lybrand TP, Marnett LJ, Breyer RM (2005) Mol Pharmacol 67: 640-7 Persistence of high density lipoprotein particles in obese mice lacking apolipoprotein A-I. Gruen ML, Plummer MR, Zhang W, Posey KA, Linton MF, Fazio S, Hasty AH (2005) J Lipid Res 46: 2007-14 Temporal and spatial pattern of expression of the HDL receptor SR-BI during murine embryogenesis. Hatzopoulos AK, Rigotti A, Rosenberg RD, Krieger M (1998) J Lipid Res 39: 495-508 Interaction of fibrinogen with staphylococcal clumping factor and with platelets. Hawiger J, Kloczewiak M, Timmons S, Strong D, Doolittle RF (1983) Ann N Y Acad Sci 408: 521-35 Expression and molecular pharmacology of the mouse CRTH2 receptor. Hata AN, Zent R, Breyer MD, Breyer RM (2003) J Pharmacol Exp Ther 306: 463-70
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.